Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Post author:admin
Post published:April 1, 2025
Post category:uncategorized

Automation and machine learning are transforming antibody discovery at LabGenius, with the EVA™ platform enabling rapid, high-throughput experimental processes.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Mice with humanized immune systems test new cancer therapeutic approach that blindfolds immune cells to the body’s self-recognition system

This International Women’s Day, Meet the Scientist Changing Women’s Health

Social media and mental health linked to rising e-cigarette use in American teens

Helpful Links

Subscribe To Us